Acadia Pharma (ACAD) Misses Q1 View By 4c
More News related to ACAD
- Acadia Pharmaceuticals (ACAD) Tops Q3 EPS by 1c
- ACADIA Pharmaceuticals Reports Third Quarter 2009 Financial Results
- ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009
- ACADIA Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26, 2009
- ACADIA Pharma (ACAD) to Cut Workforce by 50%
More News related to Earnings
- ImmunoGen (IMGN) to Make Several Poster Presentations as AACR-NCI-EORTC Conference
- BofA's Ken Lewis Sees Crisis 'Abating', But Says Banking Has 'Some Way to Go' to Recover
- Novavax (NVAX) Begins Phase IIa of Flu VLP Vaccine Candidate in Adults 60 and Over
- Catalyst Pharma (CPRX) Receives $1.2M Grant from U.S. DoD for Study of Vigabatrin
- TASER Int. (TASR) Announces U.S. Army Ordered 2500 Taser X26 ECDs
Acadia Pharma (Nasdaq: ACAD) reports Q1 EPS of ($0.40), 4 cents below the analyst estimate of ($0.36). Revenue for the quarter was $374k, versus the consensus of $540K.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
